Literature DB >> 24174376

Trends in incidence of primary cutaneous malignancies in children, adolescents, and young adults: a population-based study.

Andreza A Senerchia1, Karina B Ribeiro, Carlos Rodriguez-Galindo.   

Abstract

BACKGROUND: Skin cancer incidence among young adults is rising; however, the epidemiological characteristics of primary cutaneous lymphomas and cutaneous soft tissue sarcomas (CSTS) in individuals <30 years old has not been investigated. We analyzed the incidence and time-trends of primary cutaneous malignancies in children and adolescents/young adults (AYA). PROCEDURE: SEER-17 and -13 data were used to assess the descriptive epidemiology and time-trends in incidence of primary cutaneous malignancies in children and AYA. SEERStat and Joinpoint softwares were utilized to estimate annual percent changes (APC) in incidence.
RESULTS: In total, 7,814 cases (ASR = 25.66/1,000,000 habitants) of primary skin cancers in <30 years old were diagnosed in 2000-2008. Females had a higher incidence of melanoma (risk ratio (RR) = 1.95; P < 0.001) and a lower risk of developing CSTS (RR = 0.64, P < 0.001). Compared to whites, blacks have a lower incidence of melanoma (RR = 0.03, P < 0.001), and higher risk of CSTS (RR = 2.28, P < 0.001). Melanoma increased in females over a 15-year period (1992-2006) (APC = 2.5, 95%CI = 1.8; 3.2), and the incidence of cutaneous T-cell lymphomas increased over the period 1992-2008 (APC = 9.5, 95% CI = 6.7; 12.4). CSTS incidence decreased among males over the period 1992-1999 (APC = -21.4, 95% CI -27.2; -15.1), particularly due to a decrease in Kaposi sarcoma incidence (AAPC 1992-2008 = -13.6, 95% CI = -22.4;-3.8), although with a notable racial disparity (whites, AAPC = -15.2, 95% CI = -23.2;-6.4; blacks, AAPC = -10.6, 95% CI = -13.2;-7.9).
CONCLUSIONS: Non-melanoma skin cancer is very rare in children and AYA. We have shown variation in time-trends in incidence as well as in incidence patterns by race, sex, age, and histologic type, highlighting the importance of descriptive epidemiology to better understand the characteristics of these malignancies.
© 2013 Wiley Periodicals, Inc.

Entities:  

Keywords:  adolescent; child; incidence/trends; skin neoplasms; young adult

Mesh:

Year:  2013        PMID: 24174376     DOI: 10.1002/pbc.24639

Source DB:  PubMed          Journal:  Pediatr Blood Cancer        ISSN: 1545-5009            Impact factor:   3.167


  6 in total

1.  Skin Cancer in People of Color: A Systematic Review.

Authors:  George A Zakhem; Akshay N Pulavarty; Jenna C Lester; Mary L Stevenson
Journal:  Am J Clin Dermatol       Date:  2021-12-13       Impact factor: 7.403

2.  Epidemiology of malignant cutaneous granular cell tumors: A US population-based cohort analysis using the Surveillance, Epidemiology, and End Results (SEER) database.

Authors:  Fatima N Mirza; Charles T Tuggle; Cheryl K Zogg; Humza N Mirza; Deepak Narayan
Journal:  J Am Acad Dermatol       Date:  2017-10-05       Impact factor: 11.527

3.  Multiple skin neoplasms in subjects under 40 years of age in Goiania, Brazil.

Authors:  Samir Pereira; Maria Paula Curado; Ana Maria Quinteiro Ribeiro
Journal:  Rev Saude Publica       Date:  2015-10-09       Impact factor: 2.106

4.  Melanoma incidence trends and survival in adolescents and young adults in Queensland, Australia.

Authors:  Michelle R Iannacone; Danny R Youlden; Peter D Baade; Joanne F Aitken; Adèle C Green
Journal:  Int J Cancer       Date:  2014-05-17       Impact factor: 7.396

5.  Higher than reported adolescent and young adult clinical trial enrollment during the "Golden Age" of melanoma clinical trials.

Authors:  Radhika Sreeraman Kumar; Ram Thapa; Youngchul Kim; Nikhil I Khushalani; Vernon K Sondak; Damon R Reed
Journal:  Cancer Med       Date:  2018-02-25       Impact factor: 4.452

6.  Web-based nomograms for predicting the prognosis of adolescent and young adult skin melanoma, a large population-based real-world analysis.

Authors:  Chen Yang; Fei Liao; Li Cao
Journal:  Transl Cancer Res       Date:  2020-11       Impact factor: 1.241

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.